Free trial ENDS
Thank you
Update on Our Recent Free Trial and Next Steps
We’re pleased to share that our free trial has concluded, and we’ve received an encouraging response from participants in over 50 countries. We are now in the process of evaluating the results for statistical analysis.
If you weren’t able to participate in the free trial, don’t worry—we’re here to help. Please feel free to reach out to us, and we’ll do our best to assist you on a case-by-case basis. We are also exploring the possibility of offering this service on a fee-for-service basis in the near future.
The process
Glioma AI has been trained on all field strengths and all MRI vendors’ machines to overcome the inter-scanner and inter-institutional protocol variation. Therefore, there are no limitations to sharing MRI images from any scanner or scanning protocol as long as you have T1, T2, FLAIR, DWI, and T1 post-contrast sequences. If you are a patient or a patient’s caretaker, do not worry about sequences, we will inform you if the scan you have sent has the appropriate sequences for Glioma AI evaluation.
Data privacy
After uploading the MRI brain scan. We will check it for anonymization, if a scan is not anonymized, we will anonymize it before feeding it into Glioma AI. Glioma AI will give the prediction about glioma genotype. A neuroradiologist will also analyze the scan independently and will be blinded to the prediction from Glioma AI. These hybrid results will be sent to you by email. If there is a discrepancy between Glioma AI and human experts, a comment from the expert would be included in the predictions sent. After the prediction task, your MRI data will be deleted from Glioma AI. The anonymised MRI images will be saved for educational purposes in the Brain Tumor Imaging Organisation archive, which provides expert neuroradiology opinions about the scans.
Disclaimer
The opinions from neuroradiologists and Glioma AI would only be pertaining to the glioma genotypes and will not contain management advice. Neuroradiologists or Glioma AI will not be liable for any harm caused directly or indirectly by predictions offered, as no AI or human is 100% accurate. However, we want to emphasize that we understand the seriousness of wrong predictions. Every wrong prediction would be carefully evaluated and presented in the Glioma AI discrepancy meeting. These erroneous prediction results will also be individually published, and you will be informed of those publications. We will welcome suggestions and feedback from you.
Talk to us
If you want to get involved in checking out Glioma AI performance, please upload the scan from contact us page.